| |
| |
|
| Insider
Information: |
Hull Hans |
| Relationship: |
Chief Business Officer |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
353,779 |
|
|
Indirect Shares
|
31,791 |
|
|
| Direct
Value |
$1,333,681 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
385,570 |
|
|
| Total
Value |
$1,333,681 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adverum Biotechnologies, Inc |
ADVM |
Chief Executive Officer |
2015-08-21 |
137,210 |
2014-08-05 |
0 |
Premium* |
|
|
Pliant Therapeutics, Inc. |
PLRX |
Chief Business Officer |
2024-01-23 |
216,569 |
2024-01-23 |
31,791 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
31,500 |
216,569 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• – – |
2024-01-17 |
4 |
AS |
$17.23 |
$168,613 |
D/D |
(9,786) |
185,069 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• – – |
2023-08-04 |
4 |
AS |
$20.01 |
$401,201 |
D/D |
(20,050) |
194,855 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• – – |
2023-08-04 |
4 |
OE |
$2.08 |
$18,285 |
D/D |
8,791 |
214,905 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• – – |
2023-08-03 |
4 |
AS |
$20.00 |
$261,380 |
D/D |
(13,069) |
206,114 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• – – |
2023-08-03 |
4 |
OE |
$2.08 |
$3,744 |
D/D |
1,800 |
207,914 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• – – |
2023-08-03 |
4 |
S |
$20.00 |
$36,000 |
D/D |
(1,800) |
206,114 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• – – |
2023-07-17 |
4 |
AS |
$18.01 |
$323,029 |
D/D |
(17,937) |
219,183 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• – – |
2023-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
35,156 |
237,120 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• • – |
2023-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
54,000 |
192,191 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• • – |
2022-12-20 |
4 |
S |
$19.10 |
$167,108 |
D/D |
(8,748) |
138,191 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• • – |
2022-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
17,578 |
146,939 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• – – |
2021-05-26 |
4 |
OE |
$2.08 |
$9,360 |
D/D |
4,500 |
125,246 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• – – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
I/I |
3,821 |
3,821 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business Officer |
• – – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,079 |
117,246 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business OfficerOfficer |
• – – |
2020-06-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
27,970 |
|
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Business OfficerOfficer |
• – – |
2020-06-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
112,167 |
|
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Chief Executive Officer |
• – – |
2015-08-21 |
4 |
A |
$0.00 |
$0 |
D/D |
117,590 |
137,210 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
SVP, Business Operations |
• – – |
2015-06-12 |
4 |
OE |
$0.19 |
$1,577 |
D/D |
8,300 |
19,620 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
SVP, Business Operations |
• – – |
2015-06-04 |
4 |
OE |
$0.19 |
$380 |
D/D |
2,000 |
13,320 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
SVP, Business Operations |
• – – |
2015-06-04 |
4 |
AS |
$37.64 |
$75,283 |
D/D |
(2,000) |
11,320 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
SVP, Business Operations |
• – – |
2015-05-04 |
4 |
AS |
$30.87 |
$154,349 |
D/D |
(5,000) |
11,320 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
SVP, Business Operations |
• – – |
2015-05-04 |
4 |
OE |
$0.19 |
$950 |
D/D |
5,000 |
16,320 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
SVP, Business Operations |
• – – |
2015-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
11,320 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
SVP, Business Operations |
• – – |
2015-04-07 |
4 |
AS |
$38.59 |
$1,061,573 |
D/D |
(27,500) |
3,320 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
